{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T19:27:55Z","timestamp":1793042875746,"version":"4.5.0"},"reference-count":41,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T00:00:00Z","timestamp":1671494400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: To determine the antibiotic resistance rate of H. pylori among patients with peptic ulcer. Materials and Methods: A cross-sectional monocentric study was conducted from January to December 2021 among patients aged from 16 years with gastrointestinal symptoms and esophagogastroduodenoscopy. Gastric mucosa biopsies were collected at the edges of the ulcer or at lesion sites for H. pylori culture. Five antibiotics (amoxicillin (AMX), clarithromycin (CLR), metronidazole (MTZ), levofloxacin (LEV), and tetracycline (TET)) were selected for antibiotic susceptibility testing. Results: One hundred and twenty-five patients were included, and the sex ratio was 0.6. Their mean age was 47.3 \u00b1 14.2 years. All of the participants had gastritis, and 24.0% had duodenitis. A total of 21.6% of patients had a duodenal ulcer, and 12.8% had an antral ulcer. A total of 40 specimens have grown in H. pylori culture. The proportion of resistance to AMX, CLR, MTZ, LEV, and TET was 27.5%, 50%, 67.5%, 35%, and 5%, respectively. The proportion of multidrug resistance was 22.5%. The proportion of double resistance to AMX + CLR was 20.0%, AMX + MTZ was 15.0%, AMX + LEV was 2.5%, CLR + MTZ was 32.5%, and TET + MTZ was 5.0%. Conclusions: Our research results show that the treatment with MTX-TET or LVX-AMOX has the highest sensitivity rate. Therefore, practitioners should refer to these regimes to eradicate H. pylori in patients with gastric and duodenal ulcers. The reports on H. pylori eradication from different geographic areas show heterogeneous results. Therefore, continuous monitoring of antibiotic resistance of H. pylori in each population is very important. Having evidence helps clinicians to treat patients most effectively, reduce treatment costs, and limit the rate of antibiotic resistance.<\/jats:p>","DOI":"10.3390\/medicina59010006","type":"journal-article","created":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T02:58:27Z","timestamp":1671591507000},"page":"6","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Antibiotic Resistance of Helicobacter pylori in Patients with Peptic Ulcer"],"prefix":"10.3390","volume":"59","author":[{"given":"Thanh Binh","family":"Vu","sequence":"first","affiliation":[{"name":"Thai Binh University of Medicine and Pharmacy, Thai Binh 410000, Vietnam"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thi Nhu Quynh","family":"Tran","sequence":"additional","affiliation":[{"name":"Thai Binh University of Medicine and Pharmacy, Thai Binh 410000, Vietnam"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thi Quynh Anh","family":"Tran","sequence":"additional","affiliation":[{"name":"Thai Binh Department of Health, Thai Binh 410000, Vietnam"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinh Luong","family":"Vu","sequence":"additional","affiliation":[{"name":"Thai Binh University of Medicine and Pharmacy, Thai Binh 410000, Vietnam"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1369-8615","authenticated-orcid":false,"given":"Van Thuan","family":"Hoang","sequence":"additional","affiliation":[{"name":"Thai Binh University of Medicine and Pharmacy, Thai Binh 410000, Vietnam"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,12,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1128\/CMR.00011-10","article-title":"Helicobacter Pylori and Gastric Cancer: Factors That Modulate Disease Risk","volume":"23","author":"Wroblewski","year":"2010","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/hel.12165","article-title":"Epidemiology of Helicobacter Pylori Infection","volume":"19","author":"Eusebi","year":"2014","journal-title":"Helicobacter"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"101404","DOI":"10.1016\/j.eclinm.2022.101404","article-title":"The current and future incidence and mortality of gastric cancer in 185 countries, 2020\u20132040: A population-based modelling study","volume":"47","author":"Morgan","year":"2022","journal-title":"EClinicalMedicine"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"5660","DOI":"10.3748\/wjg.v20.i19.5660","article-title":"Helicobacter Pylori Eradication for Preventing Gastric Cancer","volume":"20","author":"Lu","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1007\/s11938-020-00300-3","article-title":"Update on the Management of Helicobacter Pylori Infection","volume":"18","author":"Saleem","year":"2020","journal-title":"Curr. Treat. Options Gastroenterol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1136\/gut.2006.101634","article-title":"Current Concepts in the Management of Helicobacter Pylori Infection: The Maastricht III Consensus Report","volume":"56","author":"Malfertheiner","year":"2007","journal-title":"Gut"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1136\/gutjnl-2012-302084","article-title":"Management of Helicobacter Pylori Infection\u2014The Maastricht IV\/Florence Consensus Report","volume":"61","author":"Malfertheiner","year":"2012","journal-title":"Gut"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13099-021-00452-2","article-title":"The Endemic Helicobacter Pylori Population in Southern Vietnam Has Both South East Asian and European Origins","volume":"13","author":"Nguyen","year":"2021","journal-title":"Gut Pathog."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1128\/CDLI.12.1.81-85.2005","article-title":"Seroprevalence of Helicobacter Pylori Infection in Urban and Rural Vietnam","volume":"12","author":"Hoang","year":"2005","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Binh, T.T., Tuan, V.P., Dung, H.D.Q., Tung, P.H., Tri, T.D., Thuan, N.P.M., Tam, L.Q., Nam, B.C., Giang, D.A., and Hoan, P.Q. (2018). Molecular Epidemiology of Helicobacter Pylori Infection in a Minor Ethnic Group of Vietnam: A Multiethnic, Population-Based Study. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19030708"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Tran, T.T., Nguyen, A.T., Quach, D.T., Pham, D.T.-H., Cao, N.M., Nguyen, U.T.-H., Dang, A.N.-T., Tran, M.A., Quach, L.H., and Tran, K.T. (2022). Emergence of Amoxicillin Resistance and Identification of Novel Mutations of the Pbp1A Gene in Helicobacter Pylori in Vietnam. BMC Microbiol., 22.","DOI":"10.1186\/s12866-022-02463-8"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1093\/jac\/dkr359","article-title":"BSAC Working Party on Susceptibility Testing BSAC Standardized Disc Susceptibility Testing Method (Version 10)","volume":"66","author":"Andrews","year":"2011","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_13","unstructured":"B\u1ed9 Y T\u1ebf. C\u1ee5c Qu\u1ea3n L\u00fd Kh\u00e1m Ch\u1eefa B\u1ec7nh (2022, November 12). Quy\u1ebft \u0111\u1ecbnh s\u1ed1 6769\/Q\u0110-BYT Ng\u00e0y 08 Th\u00e1ng 11 N\u0103m 2018 C\u1ee7a B\u1ed9 Tr\u01b0\u1edfng B\u1ed9 Y T\u1ebf V\u1ec1 Vi\u1ec7c Ban H\u00e0nh T\u00e0i\u2026. Available online: https:\/\/kcb.vn\/quy-trinh\/quyet-dinh-so-6769-qd-byt-ngay-08-thang-11-nam-2018-cua-bo-t.html."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Le, L.T.T., Nguyen, T.A., Nguyen, N.A., Nguyen, Y.T.H., Nguyen, H.T.B., Nguyen, L.T., Vi, M.T., and Nguyen, T. (2022). Helicobacter Pylori Eradication Efficacy of Therapy Based on the Antimicrobial Susceptibility in Children with Gastritis and Peptic Ulcer in Mekong Delta, Vietnam. Children, 9.","DOI":"10.3390\/children9071019"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Le, L.T.T., Nguyen, T.A., Nguyen, N.A., Nguyen, Y.T.H., Nguyen, H.T.B., Nguyen, L.T., Vi, M.T., and Nguyen, T. (2022). Antibiotic Resistance of Helicobacter Pylori in Children with Gastritis and Peptic Ulcers in Mekong Delta, Vietnam. Healthcare, 10.","DOI":"10.3390\/healthcare10061121"},{"key":"ref_16","unstructured":"EUCAST (2022, November 12). Breakpoint Tables for Interpretation of MICs and Zone Diameters, Version 8.0. Available online: http:\/\/www.eucast.org\/ast_of_bacteria\/previous_versions_of_documents\/."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"117","DOI":"10.12816\/0014424","article-title":"Low Recovery Rate of Helicobacter Pylori from Positive CLO Test Patients Suffering from Dyspepsia","volume":"37","author":"SBIM","year":"2015","journal-title":"Bahrain Med. Bull."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Galo\u0219, F., N\u0103stase, G., Boboc, C., Coldea, C., Anghel, M., Orzan, A., and B\u0103lgr\u0103dean, M. (2018). A Study of the Correlation between Bacterial Culture and Histological Examination in Children with Helicobacter Pylori Gastritis, IntechOpen.","DOI":"10.5772\/intechopen.80257"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"12818","DOI":"10.3748\/wjg.v20.i36.12818","article-title":"Hematologic Manifestations of Helicobacter Pylori Infection","volume":"20","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/MCG.0b013e3182676e2b","article-title":"The Incidence of Primary Antibiotic Resistance of Helicobacter Pylori in Vietnam","volume":"47","author":"Binh","year":"2013","journal-title":"J. Clin. Gastroenterol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.3346\/jkms.2020.35.e33","article-title":"Comparison of 7- and 14-Day Eradication Therapy for Helicobacter Pylori with First- and Second-Line Regimen: Randomized Clinical Trial","volume":"35","author":"Kim","year":"2020","journal-title":"J. Korean Med. Sci."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1046\/j.1365-2036.2000.00659.x","article-title":"Omeprazole or Ranitidine Bismuth Citrate Triple Therapy to Treat Helicobacter Pylori Infection: A Randomized, Controlled Trial in Vietnamese Patients with Duodenal Ulcer","volume":"14","author":"Mao","year":"2000","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_24","first-page":"303","article-title":"Efficacy of Sequential Regimens for the Eradication of Helicobacter Pylori in Patients with Peptic Ulcer Disease","volume":"15","author":"Hoang","year":"2011","journal-title":"J. Med. Hochiminh City"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Dao, L.V., Dao, H.V., Nguyen, H.T., Vu, V.T., Tran, A.T.N., Dat, V.Q., Hoang, L.B., Nguyen, H.T.V., and Nguyen, T.D. (2021). Helicobacter Pylori Infection and Eradication Outcomes among Vietnamese Patients in the Same Households: Findings from a Non-Randomized Study. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0260454"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/s41575-021-00449-x","article-title":"Helicobacter Pylori Infection and Antibiotic Resistance\u2014From Biology to Clinical Implications","volume":"18","author":"Yamaoka","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1111\/j.1440-1746.2009.05982.x","article-title":"Second Asia-Pacific Consensus Guidelines for Helicobacter Pylori Infection","volume":"24","author":"Fock","year":"2009","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1038\/s41467-021-22557-7","article-title":"Primary and Secondary Clarithromycin Resistance in Helicobacter Pylori and Mathematical Modeling of the Role of Macrolides","volume":"12","author":"Szirtes","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1523-5378.2007.00518.x","article-title":"A Report Card to Grade Helicobacter Pylori Therapy","volume":"12","author":"Graham","year":"2007","journal-title":"Helicobacter"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.3748\/wjg.v23.i16.2854","article-title":"Importance of Antimicrobial Susceptibility Testing for the Management of Eradication in Helicobacter Pylori Infection","volume":"23","author":"Arslan","year":"2017","journal-title":"World J. Gastroenterol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S2468-1253(17)30219-4","article-title":"Primary Antibiotic Resistance in Helicobacter Pylori in the Asia-Pacific Region: A Systematic Review and Meta-Analysis","volume":"2","author":"Kuo","year":"2017","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1136\/gut.2003.022111","article-title":"H Pylori Antibiotic Resistance: Prevalence, Importance, and Advances in Testing","volume":"53","year":"2004","journal-title":"Gut"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1365-2036.2007.03386.x","article-title":"Meta-Analysis: The Effect of Antibiotic Resistance Status on the Efficacy of Triple and Quadruple First-Line Therapies for Helicobacter Pylori","volume":"26","author":"Fischbach","year":"2007","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_34","first-page":"409","article-title":"Worldwide H pylori Antibiotic Resistance: A Systematic Review","volume":"19","author":"Giorgio","year":"2010","journal-title":"J. Gastrointest. Liver Dis."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1136\/gutjnl-2012-302254","article-title":"Study Group participants Helicobacter Pylori Resistance to Antibiotics in Europe and Its Relationship to Antibiotic Consumption","volume":"62","author":"Megraud","year":"2013","journal-title":"Gut"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1365-2036.2006.02737.x","article-title":"Systematic Review and Meta-Analysis: Levofloxacin-Based Rescue Regimens after Helicobacter Pylori Treatment Failure","volume":"23","author":"Gisbert","year":"2006","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1177\/1756283X09347109","article-title":"Second-Line Rescue Therapy of Helicobacter Pylori Infection","volume":"2","author":"Gisbert","year":"2009","journal-title":"Ther. Adv. Gastroenterol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1128\/AAC.00614-06","article-title":"Quinolone Resistance in Helicobacter Pylori Isolates in Germany","volume":"51","author":"Glocker","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.dld.2007.06.016","article-title":"Levofloxacin-Based Triple Therapy for Helicobacter Pylori Re-Treatment: Role of Bacterial Resistance","volume":"39","author":"Perna","year":"2007","journal-title":"Dig. Liver Dis."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1523-5378.2010.00816.x","article-title":"Analysis of Antibiotic Susceptibility Patterns of Helicobacter Pylori Isolates from Malaysia","volume":"16","author":"Ahmad","year":"2011","journal-title":"Helicobacter"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3389\/fmolb.2014.00019","article-title":"Mechanisms of Helicobacter pylori antibiotic resistance and molecular testing","volume":"1","author":"Nishizawa","year":"2014","journal-title":"Front. Mol. Biosci."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/59\/1\/6\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:44:51Z","timestamp":1760147091000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/59\/1\/6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,20]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1]]}},"alternative-id":["medicina59010006"],"URL":"https:\/\/doi.org\/10.3390\/medicina59010006","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,20]]}}}